Traditional Chinese Medicine Fuzheng Huayu Prevents Development of Liver Fibrosis in Mice.
Fuzheng Huayu
Liver fibrosis
Reactive oxygen species
Toxic and cholestatic liver injury
Traditional Chinese medicine
Journal
Archives of clinical and biomedical research
ISSN: 2572-5017
Titre abrégé: Arch Clin Biomed Res
Pays: United States
ID NLM: 101768967
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
19
11
2020
pubmed:
20
11
2020
medline:
20
11
2020
Statut:
ppublish
Résumé
To investigate the therapeutic effect of FZHY on hepatic fibrosis in mice and to determine the mechanism of its action. Wild type mice were subjected to toxic (carbon tetrachloride, CCl FZHY strongly inhibited the development of CCl Traditional Chinese Medicine FZHY has a variety of anti-fibrotic effects, including strong anti-oxidant, anti-inflammatory and anti-fibrotic effects on myeloid cells and hepatocytes. Although FZHY compound does not seem to directly affect HSCs, it regulates HSC activation via inhibition of macrophage recruitment to fibrotic liver.
Identifiants
pubmed: 33210080
doi: 10.26502/acbr.50170125
pmc: PMC7671588
mid: NIHMS1639383
doi:
Types de publication
Journal Article
Langues
eng
Pagination
561-580Subventions
Organisme : NIAID NIH HHS
ID : R37 AI043477
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA018663
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA029019
Pays : United States
Organisme : NIDDK NIH HHS
ID : F32 DK009920
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA028550
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA022614
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK101737
Pays : United States
Organisme : NIDDK NIH HHS
ID : R56 DK088837
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK111866
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099205
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA011999
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI043477
Pays : United States
Références
Cytokine. 2011 Feb;53(2):223-30
pubmed: 21129996
Gastroenterology. 2008 May;134(6):1655-69
pubmed: 18471545
Liver Int. 2007 Sep;27(7):879-90
pubmed: 17696925
Inflamm Allergy Drug Targets. 2011 Dec;10(6):509-36
pubmed: 22150762
J Pharm Pharmacol. 2003 Nov;55(11):1561-8
pubmed: 14713368
Gut. 2009 Nov;58(11):1517-27
pubmed: 19201774
J Hepatol. 2005 Aug;43(2):317-23
pubmed: 15964094
J Clin Invest. 2005 Feb;115(2):209-18
pubmed: 15690074
Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):305-17
pubmed: 21497747
Hepatology. 2004 Nov;40(5):1222-5
pubmed: 15382153
Int J Biol Sci. 2011 Apr 27;7(5):536-50
pubmed: 21552420
Hepatology. 2010 Oct;52(4):1390-400
pubmed: 20683935
Hepatology. 2006 Feb;43(2 Suppl 1):S82-8
pubmed: 16447275
Hepatology. 2009 Jul;50(1):185-97
pubmed: 19441102
J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S84-7
pubmed: 16958681
Hepatology. 2004 Nov;40(5):1151-9
pubmed: 15389867
Zhong Xi Yi Jie He Xue Bao. 2012 May;10(5):561-8
pubmed: 22587979
J Ethnopharmacol. 2006 Apr 21;105(1-2):215-22
pubmed: 16314058
Gut. 2012 Mar;61(3):416-26
pubmed: 21813474
Methods Mol Med. 2005;117:99-113
pubmed: 16118448
J Ethnopharmacol. 2005 Aug 22;100(1-2):180-6
pubmed: 15950418
J Ethnopharmacol. 2009 Jul 6;124(1):142-50
pubmed: 19501992
World J Gastroenterol. 1998 Aug;4(4):348-353
pubmed: 11819318
Exp Biol Med (Maywood). 2008 Feb;233(2):109-22
pubmed: 18222966
Lipids Health Dis. 2012 Mar 28;11:45
pubmed: 22452814
Am J Physiol Gastrointest Liver Physiol. 2005 Aug;289(2):G308-19
pubmed: 15845871
J Hepatol. 2011 Sep;55(3):612-625
pubmed: 21251937
J Hepatol. 2012 Mar;56(3):704-13
pubmed: 22120206
Chin Med. 2009 Jun 29;4:12
pubmed: 19558726